CoChat

Serum interferon-gamma level is associated with drug-naïve major depressive disorder

Open access

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

Objectives: Major depressive disorder is a leading heterogeneous psychiatric illness manifested by persistent low mood, a feeling of sadness, and diminished interest in daily activities. Many biological, genetic, and social factors are thought to be linked with depression. But any suitable early risk assessment markers are absent for this illness. Therefore, we aimed to investigate the serum levels of IFN-γ in major depressive disorder patients to further investigate the association between serum levels of this cytokine and major depression. Methods: This prospective case-control study enrolled 120 major depressive disorder patients and 100 healthy controls matched by age, sex, and body mass index. A qualified psychiatrist diagnosed the major depressive disorder patients and evaluated healthy controls according to the Diagnostic and Statistical Manual of Mental Health Disorders (5th ed.; DSM-5). The Hamilton depression rating scale was applied for all the study participants to measure the severity of depression. Serum IFN-γ levels were measured by a commercially available enzyme-linked immunosorbent assay kit (Boster Biological Technology, Pleasanton, CA, USA). Results: This study observed that serum IFN-γ levels were significantly decreased in major depressive disorder patients compared to healthy controls. A significant negative correlation ( r = −0.375; p < 0.001) was obtained between serum IFN-γ levels and Hamilton depression scores. Receiver operating characteristic analysis showed good diagnostic performance of lowered serum IFN-γ levels in depression with an area under the curve at 0.790. Conclusion: We suggest the altered serum IFN-γ levels are associated with the pathophysiology of depression. The reduced levels of serum IFN-γ might be used as an early risk assessment tool for major depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2050312120974169

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Variations of serum interferon-gamma (IFN-γ) among the study population. A significant difference between patient and control groups at a 95% confidence interval (CI).
Figure 1. Variations of serum interferon-gamma (IFN-γ) among the study population. A significant difference between patient and control groups at a 95% confidence interval (CI).CC BY-NC · PubMed Central
Figure 2. Scatter plot of serum interferon-gamma (IFN-γ) and Ham-D scores with sex differences among MDD patients.
Figure 2. Scatter plot of serum interferon-gamma (IFN-γ) and Ham-D scores with sex differences among MDD patients.CC BY-NC · PubMed Central
Figure 3. Receiver operating characteristic (ROC) curve for serum interferon-gamma (IFN-γ). The cut-off point was detected as 1.49 pg/mL.
Figure 3. Receiver operating characteristic (ROC) curve for serum interferon-gamma (IFN-γ). The cut-off point was detected as 1.49 pg/mL.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Research works printed but not linked: 6

  1. American Psychiatric Association. Aripiprazole (Abilify): depression, major depressive disorder (MDD). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2016, https://www.ncbi.nlm.nih.gov/books/NBK409752/ (accessed 20 July 2020).
  2. Halaris A., 2009, Int Angiol, 28, 92
  3. Yarlagadda A, 2009, Psychiatry, 6, 18
  4. 10.1037/0033-2909.111.3.475 · doi:10.1037/0033-2909.111.3.475 · Paper page
  5. Hacimusalar Y, 2018, Noro Psikiyatr Ars, 55, 280
  6. Nishuty NL, 2019, Cureus, 11

Cited by

See all 46

Metadata

Authors
Daria, S., Proma, M. A., Shahriar, M., Islam, S. M. A., Bhuiyan, M. A., & Islam, M. R.
Affiliations
University of Asia Pacific (BD)
Corresponding author
Islam, Md. Rabiul
Venue
SAGE Open Medicine
Published
2020-01
Volume
8
Pages
2050312120974169-2050312120974169
ISSN
2050-3121 (ISSN-L)
OpenAlex
W3110521603
Cited by
46
References
54
Citations by year
2026: 2 · 2025: 11 · 2024: 7 · 2023: 12 · 2022: 9 · 2021: 4 · 2020: 1
FWCI
1.93
Type
journal article
Language
en
Open access
Locations
  • SAGE Open Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
major depressive disorder, interferon-gamma, serum cytokine levels, depression biomarkers, early risk assessment, depression severity, Hamilton Depression Rating Scale, depression pathophysiology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum interferon-gamma level is associated with drug-naïve major depressive disorder. https://app.cochat.ai/papers/10.1177/2050312120974169
The paper
Daria, S., Proma, M. A., Shahriar, M., Islam, S. M. A., Bhuiyan, M. A., & Islam, M. R. (2020). Serum interferon-gamma level is associated with drug-naïve major depressive disorder. SAGE Open Medicine. https://doi.org/10.1177/2050312120974169

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.